- Catalog number
- PDMR100063-01
- Size / count
- 20 µg
- Dry ice
- No
- Hazardous
- No
- Discontinued
- No
- Background
- The carcinoembryonic-antigen-related cell-adhesion molecule (CEACAM) family of proteins has been implicated in various intercellular-adhesion and intracellular-signalling-mediated effects that govern the growth and differentiation of normal and cancerous cells. CEACAM1 , also known as biliary glycoprotein I (BGP I) and CD66a , is a member of the carcinoembryonic antigen (CEA) gene family which belongs to the immunoglobulin superfamily. The highly glycosylated CEACAM1 contains one N-terminal V-type Ig-like domain and three C2-type Ig-like domains within its ECD , and one ITIM motif and a calmodulin binding site in the cytoplasmic region. CEACAM1 is a surface glycoprotein expressed on various blood cells , epithelial cells , and vascular cells. It was described as an adhesion molecule mediating cell adhesion via both homophilic and heterophilic manners , and was detected on leukocytes , epithelia , and endothelia. Studies have revealed that CEACAM1 performs actions in multiple cellular processes including tissue differentiation , angiogenesis , apoptosis , metastasis , as well as the modulation of innate and adaptive immune responses.
- Abbreviation
- CEACAM-1/CD66a
- Synonyms
- Antigen CD; meconium antigen; Biliary glycoprotein; CEAM; MHVR; BGP 1; Antigen CD66; Bgp1; Biliary glycoprotein 1; Biliary glycoprotein D; Carcinoembryonic antigen-related cell adhesion molecule 1; Carcinoembryonic Antigen-related Cell Adhesion Molecule 5; CD66; CD66a; CD66E; CEACAM5; meconium antigen 100; MHV-R; MHVR1; Murine hepatitis virus receptor; Ceacam1; CEAM1; BGP; BGP-1; BGPI; Biliary glycoprotein adhesion molecule; Carcinoembryonic antigen related cell adhesion molecule 1; carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) ; CD66a antigen
- UniProt
- P16573
- Accession Number
- P16573
- Expression System
- Mammalian
- Tag
- C-Fc
- Sequence
- Gln35-Ala425
- Endotoxin
- < 1.0 EU/mg of the protein as determined by the LAL method.
- Purity
- > 90% as determined by reducing SDS-PAGE.
- Bioactivity
- Not validated for activity
- Reconstitution
- It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.
- Shipping Conditions
- This product is provided as lyophilized powder which is shipped with ice packs.
- Storage Conditions
- Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
- Calculated Molecular Weight
- 67.9 kDa
- Observed Molecular Weight
- 90 kDa
- Formulation
- Lyophilized from a 0.2 μm filtered solution in PBS with 5% Trehalose and 5% Mannitol.
- Species
- Rat